Readout E-newsletter: Immunovant, Roivant, Sanofi, Regeneron


Thank you for reading this post, don't forget to subscribe!

Wish to keep on high of the science and politics driving biotech right this moment? Enroll to get our biotech e-newsletter in your inbox.

Morning. Right this moment, we discuss heaps about tariffs — how they may affect drugmakers, sufferers, and even Eire. Additionally, Novo Nordisk challenges Medicare over drug differentiation, and extra. 

Tariffs threaten Eire’s pharma powerhouse standing

It appears it’s only a matter of time earlier than President Trump outlines new tariffs on the prescribed drugs trade. That signifies that Eire, lengthy a pharma manufacturing haven due to beneficiant tax insurance policies and a talented workforce, now finds itself within the crosshairs of his administration, as do the numerous world drugmakers who’ve arrange store there.

STAT+ Unique Story

STAT+





This text is unique to STAT+ subscribers

Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.

Have already got an account? Log in

View All Plans

To learn the remainder of this story subscribe to STAT+.

Subscribe